The present study is the largest investigation on the use of urinary biomarkers for CI-AKIrisk stratification so far. It shows that NGAL provides prognostic information beyond the glomerular biomarkers eGFR and proteinuria
The present study is the largest investigation on the use of urinary biomarkers for CI-AKI<br>risk stratification so far. It shows that NGAL provides prognostic information beyond the glomerular biomarkers eGFR and proteinuria